← Browse by Condition
Medical Condition

kras p g12c

Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 1, Phase 2
NCT05398094 Phase 2
Recruiting

Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy

Enrollment
19 pts
Location
Spain
Sponsor
Fundación GECP
View Trial →
NCT05410145 Phase 1, Phase 2
Recruiting

A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation

Enrollment
442 pts
Location
United States, Austr...
Sponsor
D3 Bio (Wuxi) Co., Ltd
View Trial →